Orogen Non Current Liabilities Total vs Common Stock Analysis

OGN Stock

CAD 1.44 0.01 0.69%

Orogen Royalties financial indicator trend analysis is much more than just breaking down Orogen Royalties prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Orogen Royalties is a good investment. Please check the relationship between Orogen Royalties Non Current Liabilities Total and its Common Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orogen Royalties. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Non Current Liabilities Total vs Common Stock

Non Current Liabilities Total vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Orogen Royalties Non Current Liabilities Total account and Common Stock. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Orogen Royalties' Non Current Liabilities Total and Common Stock is 0.85. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Common Stock in the same time period over historical financial statements of Orogen Royalties, assuming nothing else is changed. The correlation between historical values of Orogen Royalties' Non Current Liabilities Total and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Orogen Royalties are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Non Current Liabilities Total i.e., Orogen Royalties' Non Current Liabilities Total and Common Stock go up and down completely randomly.

Correlation Coefficient

0.85

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Non Current Liabilities Total

Common Stock

Most indicators from Orogen Royalties' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Orogen Royalties current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orogen Royalties. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Orogen Royalties' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 38.56 in 2024, despite the fact that Tax Provision is likely to grow to (1.1 M).

	2021	2022	2023	2024 (projected)
Interest Income	100.1K	89.9K	256.6K	269.4K
Net Interest Income	100.1K	89.9K	256.6K	269.4K

Interest Income Net Interest Income

Orogen Royalties fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Non Current Liabilities Total	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Common Stock Shares Outstanding	Short Term Investments	Other Stockholder Equity	Net Invested Capital	Net Working Capital	Capital Stock	Property Plant And Equipment Net	Capital Lease Obligations
Total Assets		-0.07	0.19	1.0	0.9	0.91	-0.85	0.9	0.49	0.98	0.68	0.75	0.96	0.76	0.26	0.79	0.92	0.89	0.87	0.81	0.69	0.94	0.82	0.87	0.95	0.21
Other Current Liab	-0.07		0.96	-0.1	0.04	-0.06	-0.04	-0.04	0.68	-0.15	-0.05	-0.08	-0.14	-0.01	0.94	0.24	-0.06	-0.11	-0.08	0.03	-0.13	-0.1	0.03	-0.11	-0.14	0.02
Total Current Liabilities	0.19	0.96		0.16	0.28	0.18	-0.26	0.23	0.83	0.09	0.12	0.13	0.13	0.16	1.0	0.47	0.2	0.13	0.15	0.26	0.1	0.13	0.28	0.12	0.09	0.08
Total Stockholder Equity	1.0	-0.1	0.16		0.89	0.9	-0.85	0.9	0.46	0.99	0.68	0.75	0.97	0.75	0.22	0.78	0.92	0.89	0.87	0.81	0.69	0.94	0.82	0.87	0.95	0.2
Other Liab	0.9	0.04	0.28	0.89		0.97	-0.87	0.78	0.51	0.86	0.72	0.74	0.83	0.77	0.35	0.79	0.97	0.97	0.94	0.81	0.6	0.83	0.8	0.95	0.82	0.55
Net Tangible Assets	0.91	-0.06	0.18	0.9	0.97		-0.94	0.79	0.45	0.86	0.83	0.86	0.84	0.85	0.26	0.81	1.0	0.99	0.98	0.87	0.59	0.85	0.84	0.97	0.83	0.58
Retained Earnings	-0.85	-0.04	-0.26	-0.85	-0.87	-0.94		-0.67	-0.47	-0.8	-0.95	-0.93	-0.73	-0.95	-0.34	-0.84	-0.94	-0.9	-0.94	-0.9	-0.39	-0.83	-0.83	-0.91	-0.8	-0.6
Accounts Payable	0.9	-0.04	0.23	0.9	0.78	0.79	-0.67		0.59	0.85	0.49	0.63	0.96	0.48	0.26	0.75	0.81	0.77	0.71	0.74	0.86	0.77	0.79	0.71	0.77	0.04
Cash	0.49	0.68	0.83	0.46	0.51	0.45	-0.47	0.59		0.35	0.3	0.42	0.47	0.29	0.84	0.81	0.47	0.37	0.41	0.65	0.49	0.42	0.71	0.36	0.32	0.08
Non Current Assets Total	0.98	-0.15	0.09	0.99	0.86	0.86	-0.8	0.85	0.35		0.64	0.7	0.94	0.73	0.16	0.68	0.87	0.87	0.84	0.71	0.65	0.94	0.73	0.85	0.97	0.16
Non Currrent Assets Other	0.68	-0.05	0.12	0.68	0.72	0.83	-0.95	0.49	0.3	0.64		0.94	0.54	0.94	0.21	0.72	0.84	0.8	0.86	0.82	0.19	0.69	0.71	0.81	0.65	0.69
Other Assets	0.75	-0.08	0.13	0.75	0.74	0.86	-0.93	0.63	0.42	0.7	0.94		0.66	0.88	0.21	0.83	0.87	0.82	0.9	0.9	0.46	0.8	0.85	0.86	0.73	0.57
Net Receivables	0.96	-0.14	0.13	0.97	0.83	0.84	-0.73	0.96	0.47	0.94	0.54	0.66		0.6	0.18	0.73	0.86	0.83	0.77	0.74	0.83	0.86	0.79	0.78	0.87	0.05
Non Current Liabilities Total	0.76	-0.01	0.16	0.75	0.77	0.85	-0.95	0.48	0.29	0.73	0.94	0.88	0.6		0.25	0.7	0.85	0.82	0.88	0.78	0.22	0.78	0.69	0.85	0.76	0.61
Total Liab	0.26	0.94	1.0	0.22	0.35	0.26	-0.34	0.26	0.84	0.16	0.21	0.21	0.18	0.25		0.52	0.27	0.2	0.23	0.33	0.12	0.2	0.34	0.2	0.15	0.14
Total Current Assets	0.79	0.24	0.47	0.78	0.79	0.81	-0.84	0.75	0.81	0.68	0.72	0.83	0.73	0.7	0.52		0.83	0.74	0.81	0.97	0.61	0.79	0.98	0.75	0.68	0.36
Common Stock	0.92	-0.06	0.2	0.92	0.97	1.0	-0.94	0.81	0.47	0.87	0.84	0.87	0.86	0.85	0.27	0.83		0.99	0.97	0.88	0.61	0.86	0.85	0.97	0.84	0.55
Property Plant Equipment	0.89	-0.11	0.13	0.89	0.97	0.99	-0.9	0.77	0.37	0.87	0.8	0.82	0.83	0.82	0.2	0.74	0.99		0.97	0.81	0.59	0.84	0.77	0.98	0.84	0.59
Common Stock Shares Outstanding	0.87	-0.08	0.15	0.87	0.94	0.98	-0.94	0.71	0.41	0.84	0.86	0.9	0.77	0.88	0.23	0.81	0.97	0.97		0.88	0.54	0.89	0.84	0.99	0.85	0.64
Short Term Investments	0.81	0.03	0.26	0.81	0.81	0.87	-0.9	0.74	0.65	0.71	0.82	0.9	0.74	0.78	0.33	0.97	0.88	0.81	0.88		0.57	0.81	0.98	0.82	0.71	0.45
Other Stockholder Equity	0.69	-0.13	0.1	0.69	0.6	0.59	-0.39	0.86	0.49	0.65	0.19	0.46	0.83	0.22	0.12	0.61	0.61	0.59	0.54	0.57		0.62	0.68	0.56	0.59	-0.09
Net Invested Capital	0.94	-0.1	0.13	0.94	0.83	0.85	-0.83	0.77	0.42	0.94	0.69	0.8	0.86	0.78	0.2	0.79	0.86	0.84	0.89	0.81	0.62		0.82	0.88	0.98	0.25
Net Working Capital	0.82	0.03	0.28	0.82	0.8	0.84	-0.83	0.79	0.71	0.73	0.71	0.85	0.79	0.69	0.34	0.98	0.85	0.77	0.84	0.98	0.68	0.82		0.79	0.72	0.33
Capital Stock	0.87	-0.11	0.12	0.87	0.95	0.97	-0.91	0.71	0.36	0.85	0.81	0.86	0.78	0.85	0.2	0.75	0.97	0.98	0.99	0.82	0.56	0.88	0.79		0.86	0.63
Property Plant And Equipment Net	0.95	-0.14	0.09	0.95	0.82	0.83	-0.8	0.77	0.32	0.97	0.65	0.73	0.87	0.76	0.15	0.68	0.84	0.84	0.85	0.71	0.59	0.98	0.72	0.86		0.2
Capital Lease Obligations	0.21	0.02	0.08	0.2	0.55	0.58	-0.6	0.04	0.08	0.16	0.69	0.57	0.05	0.61	0.14	0.36	0.55	0.59	0.64	0.45	-0.09	0.25	0.33	0.63	0.2

Click cells to compare fundamentals

Orogen Royalties Account Relationship Matchups

Orogen Royalties fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.4M	11.9M	51.7M	53.1M	62.6M	65.7M
Other Current Liab	91.4K	592.0K	435.0K	172.1K	139.0K	132.1K
Total Current Liabilities	339.6K	867.8K	683.5K	648.7K	878.5K	835.6K
Total Stockholder Equity	10.0M	10.9M	50.7M	52.3M	61.6M	64.7M
Other Liab	46.2K	66.5K	5.3K	128.7K	148K	155.4K
Net Tangible Assets	12.7M	10.0M	52.3M	50.7M	58.3M	61.2M
Retained Earnings	(18.5M)	(22.4M)	(25.2M)	(24.4M)	(21.3M)	(22.4M)
Accounts Payable	130.3K	69.3K	121.9K	301.8K	528.6K	555.0K
Cash	3.5M	3.6M	2.4M	3.7M	6.4M	4.7M
Non Current Assets Total	441.7K	637.1K	40.7M	40.4M	43.2M	45.4M
Non Currrent Assets Other	173.3K	207.2K	209.4K	206.6K	115.8K	139.7K
Other Assets	64.2K	203.9K	207.2K	209.4K	240.8K	138.9K
Net Receivables	346.6K	98.9K	1.3M	1.2M	2.3M	2.4M
Non Current Liabilities Total	128.5K	177.8K	291.1K	184.5K	133.3K	145.2K
Total Liab	468.1K	1.0M	974.6K	833.2K	1.0M	941.2K
Total Current Assets	10.0M	11.3M	10.9M	12.7M	19.4M	11.9M
Common Stock	27.2M	27.5M	71.2M	72.3M	83.1M	87.3M
Property Plant Equipment	96.2K	237.8K	41.9M	40.5M	46.6M	48.9M
Common Stock Shares Outstanding	85.3M	174.6M	178.1M	179.2M	193.4M	151.0M
Short Term Investments	6.1M	7.2M	6.7M	7.7M	10.5M	7.1M
Net Invested Capital	10.0M	10.9M	50.7M	52.3M	61.6M	31.7M
Net Working Capital	9.7M	10.4M	10.2M	12.1M	18.5M	12.1M
Capital Stock	27.5M	71.2M	72.3M	72.7M	79.6M	64.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Orogen Stock Analysis

When running Orogen Royalties' price analysis, check to measure Orogen Royalties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orogen Royalties is operating at the current time. Most of Orogen Royalties' value examination focuses on studying past and present price action to predict the probability of Orogen Royalties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orogen Royalties' price. Additionally, you may evaluate how the addition of Orogen Royalties to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC